申请人:Nakashima Hisashi
公开号:US20100144694A1
公开(公告)日:2010-06-10
[Object]
It is to provide a novel compound useful for preventing and/or treating diseases that involves 11β-hydroxysteroid dehydrogenase 1 (in particular diabetes, insulin resistance, diabetes complication, obesity, dyslipidemia, hypertension, fatty liver, or metabolic syndrome).
[Means to Solve the Object]
A 1,2-diazetidin-3-one derivative represented by the following general formula (1) or salt thereof, or their solvate.
提供一种新型化合物,用于预防和/或治疗涉及11β-羟基类固醇脱氢酶1(特别是糖尿病、胰岛素抵抗、糖尿病并发症、肥胖、血脂异常、高血压、脂肪肝或代谢综合征)的疾病。通过以下一般式(1)所代表的1,2-二氮杂环丙酮衍生物或其盐,或其溶剂化合物来解决该问题。